Profound Medical Corp.

PROF | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.12

+$0.02 (+0.33%)

Sep 22, 2026, 11:44 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.33%

(1D)

Rating

Updated: Aug 13, 2026

25.5

Fundamentals Weak

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $222.2M

1D Range

5.99 6.19

52W Range

4.17 8.95

Valuation (TTM)

PE -12.98

PB 4.45

EV/EBITDA -5.68

Valuation (NTM)

Forward PE N/A

Forward PEG 0.22

Price Target $11

Cash Flow

FCF Yield -16.4%

SBC Adj. FCF Yield -18.6%

SBC Impact -13.7%

Margins

Gross Margin 71.7%

Operating Margin -185.4%

FCF Margin -191.3%

Growth (CAGR)

Revenue 3Y | 5Y 33.6% | 15.1%

Dil EPS 3Y | 5Y 36.0% | 15.8%

FCF 3Y | 5Y -23.0% | -13.0%

Returns

ROA -52.0%

ROE -62.5%

ROIC -60.5%

Financial Health

Net Cash

$33.65M

Current Ratio 6.46

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative p...

Sector Healthcare

Industry Medical - Devices

Employees 162

IPO Date Oct 28, 2019

Website www.profoundmedical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11

Upside

+79.74%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞